Kiniksa Pharmaceuticals International PLC — AI technical analysis, September 2026
NYSE/NASDAQ · Biotechnology
AI Recommendation
HOLD
Technical score 80/100
Last price: $77.62 · 52W range $35.20 – $82.94
Short answer
Should you buy KNSA right now? Stockgaide's AI rates KNSA as
HOLD, with a technical score of
80/100 at a last price of $77.62.
The 50-day average is above the 200-day average, and RSI sits at 46.8.
Wall Street's consensus rating is 1.71/5.
Full AI analysis for KNSA
Strategic Conclusion
Recommendation: Hold
Why? Kiniksa trades near its 52-week high with a rich P/E of 72.7, leaving limited margin of safety. The medium-term trend is positive (SMA50 > SMA200) and analysts are strongly bullish, but short-term momentum has turned mixed: MACD is below its signal line and RSI is neutral. Upside now depends on continued earnings delivery, so chasing at current levels is risky.
Ideal profile: Long-term investor willing to hold through volatility; not ideal for short-term traders seeking immediate momentum.
Price range: Entry zone $70–$74 (near SMA50); resistance at $82.94; stop-loss below $68 if holding.
Practical action: Do not chase at $77.62. Wait for a pullback toward $73–$74 or a confirmed MACD crossover above signal before adding. Existing holders can maintain position with a stop near $68.
1. Recent Price & Momentum
Current price of $77.62 is 93.6% of the 52-week high ($82.94) and more than 2.2x the 52-week low ($35.20) — clearly near the top of its range.
Price is above both SMA50 ($73.77) and SMA200 ($54.10), confirming a strong medium-term uptrend.
Short-term scenario: likely consolidation between $73.77 and $82.94; a break above $82.94 could resume the uptrend, while a loss of $73.77 would signal a deeper pullback.
2. Valuation (P/E)
P/E TTM of 72.70 is very expensive for a biopharma, implying the market already prices in significant future growth.
The multiple leaves little room for earnings misses or pipeline setbacks; valuation is a key risk at this price level.
3. Technical Analysis
SMA50 vs SMA200: SMA50 ($73.77) is above SMA200 ($54.10) — golden-cross territory, medium-term uptrend intact.
RSI(14): 46.8 — neutral, no overbought or oversold signal.
MACD: 0.5131 vs signal 1.2027, histogram -0.6895 — bearish momentum, suggesting the recent rally is losing steam.
Technical score: 80/100 → BUY, but this is driven mainly by the moving-average structure and analyst sentiment, not by current momentum.
4. Analyst Consensus
Mean rating 1.71/5 with 13 buy, 1 hold, 0 sell — analysts lean strongly bullish.
This aligns with the long-term uptrend but diverges from the near-term MACD weakness and rich valuation, reinforcing the case for patience rather than chasing.
Technical signal details
Rule-based read from price and momentum indicators only — the score behind the AI's recommendation above. Technical score: 80/100 (BUY).
50-day moving average is above the 200-day — medium-term uptrend (golden-cross territory).
MACD is below its signal line — bearish momentum.
RSI at 46.79 — neutral momentum.
Wall Street consensus rating of 1.71 — analysts lean Buy.
Stockgaide's AI currently rates KNSA as HOLD, with a technical score of 80 out of 100 at a last price of $77.62. This is educational content, not investment advice.
Is KNSA in an uptrend?
KNSA's 50-day moving average (73.77) is above its 200-day moving average (54.10), which points to a medium-term uptrend.
What is KNSA's RSI today?
KNSA has a 14-day RSI of 46.8, which places it in neutral territory (above 70 is overbought, below 30 is oversold).
What do analysts say about KNSA?
Wall Street analysts covering KNSA have a consensus rating of 1.71 out of 5 (1 = Strong Buy), meaning they lean Buy — 13 Buy · 1 Hold · 0 Sell.
Where is KNSA trading in its 52-week range?
KNSA last traded at $77.62, against a 52-week range of $35.20 to $82.94 — about 89% of the way up that range.
Get the full AI analysis of KNSA
Price targets, fundamentals deep-dive and an AI-written report — free, no signup.